Bettering BCG: a tough task for a TB vaccine?
William Bishai, Zuri Sullivan, Barry R Bloom, Peter Andersen
Author Information
- William Bishai: KwaZulu-Natal Research Institute for Tuberculosis and HIV, Durban, South Africa and Johns Hopkins University, Baltimore, Maryland, USA.
No abstract text available.
- Lancet. 2013 Mar 23;381(9871):1021-8
[PMID: 23391465]
- Nature. 2010 Aug 19;466(7309):973-7
[PMID: 20725040]
- Science. 2013 Mar 22;339(6126):1448-53
[PMID: 23449998]
- PLoS One. 2012;7(6):e39909
[PMID: 22768165]
- J Infect Dis. 2011 Jun 15;203(12):1832-43
[PMID: 21606542]
- PLoS One. 2009;4(4):e5264
[PMID: 19367339]
- Science. 2006 Mar 24;311(5768):1770-3
[PMID: 16497887]
- Science. 2001 Feb 23;291(5508):1544-7
[PMID: 11222859]
- Am J Epidemiol. 2013 Mar 15;177(6):556-61
[PMID: 23423215]
BCG Vaccine
Clinical Trials as Topic
Humans
Infant
Tuberculosis Vaccines
Tuberculosis, Pulmonary
Vaccines, DNA
Viral Vaccines
BCG Vaccine
MVA 85A
Tuberculosis Vaccines
Vaccines, DNA
Viral Vaccines
